Samsung Biologics Labor Unrest Fears Ease: Profit Resilience Samsung Biologics is rated Buy: labor unrest threatens production, but latest results show operating profit and net income growth despite revenue collapse, suggesting the stock’s risk discount may be excessive. 2026년 05월 05일 English
Advanced Micro Devices Gains on AI Momentum – Upside Still Possible AMD is rated Buy, led by strong profitability gains and AI momentum; revenue and net income surged, pushing the stock near highs, though high valuation makes earnings execution critical. 2026년 04월 17일 English
Grab Holdings Trades on Earnings Re-rate Potential: Key Insights Grab Holdings shows strong revenue and surge in operating and net income, but the stock still reflects uncertainty over AI, incentives, and guidance; analyst consensus is Buy with targets around $6.31. 2026년 04월 17일 English
